Plasma ACTH Test for Adrenal Disorders at Chughtai Lab

Plasma ACTH at Chughtai Lab

The Plasma Adrenocorticotropic Hormone (ACTH) test is a highly specialized endocrinology investigation used to evaluate the functional integrity of the hypothalamic-pituitary-adrenal (HPA) axis. ACTH is a polypeptide hormone synthesized and secreted by the corticotrope cells of the anterior pituitary gland. Its primary physiological role is to stimulate the adrenal cortex, specifically the zona fasciculata and zona reticularis, to produce and release glucocorticoids, primarily cortisol. Cortisol is essential for maintaining blood pressure, regulating blood glucose levels, modulating the immune response, and managing the body’s physiological response to stress. The synthesis of ACTH is regulated by Corticotropin-Releasing Hormone (CRH) secreted by the hypothalamus, and its levels are tightly controlled through a negative feedback mechanism exerted by circulating cortisol levels.

Measuring plasma ACTH levels is of paramount clinical importance in differentiating between primary and secondary adrenal disorders, as well as identifying the underlying etiology of Cushing’s syndrome. Because ACTH is highly unstable in vitro and exhibits a pronounced diurnal variation, the test requires state-of-the-art laboratory technology and meticulous pre-analytical sample handling. Chughtai Lab, a premier diagnostic institution in Pakistan, utilizes advanced chemiluminescent immunoassay (CLIA) technology to perform this delicate analysis. By maintaining a strict cold chain from the moment of sample collection to analysis, Chughtai Lab ensures the preservation of this highly labile hormone, delivering accurate and clinically actionable results to healthcare providers nationwide.

The diagnostic value of the Plasma ACTH test lies in its ability to pinpoint the exact site of endocrine dysfunction. When a patient presents with symptoms of cortisol excess or deficiency, measuring cortisol alone is often insufficient, as it does not indicate whether the pathology resides in the adrenal glands, the pituitary gland, or an ectopic source. By analyzing plasma ACTH in conjunction with serum cortisol, clinicians can establish a precise diagnosis, formulate targeted treatment plans, and monitor therapeutic efficacy. This test is particularly beneficial for patients suspected of having Addison’s disease, Cushing’s disease, pituitary hypofunction, or ectopic ACTH-producing neuroendocrine tumors.

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is critical for the accuracy of the Plasma ACTH test due to the hormone’s sensitivity to stress, diurnal rhythm, and pharmacological influences. Patients must adhere to the following preparation guidelines:

• Fasting Requirements: Patients are generally advised to fast for 8 to 12 hours prior to the blood draw. Water is permitted, but caloric intake, caffeine, and smoking must be avoided, as they can artificially elevate ACTH levels.
• Timing of Collection: Because ACTH secretion follows a diurnal pattern, peaking in the early morning (6:00 AM to 8:00 AM) and reaching its nadir around midnight, the blood sample is standardly collected between 8:00 AM and 10:00 AM. In some clinical investigations, an evening sample may also be requested to assess the loss of diurnal variation.
• Medication Management: Patients must inform their physician of all medications, supplements, and herbal remedies they are taking. Corticosteroids (such as prednisone, dexamethasone, or hydrocortisone), estrogen therapies, spironolactone, and amphetamines can significantly alter ACTH levels. These medications may need to be temporarily discontinued under strict medical supervision.
• Stress Reduction: Physical and emotional stress stimulate the release of CRH and subsequent ACTH. Patients should rest quietly for 15 to 30 minutes before the blood draw and avoid strenuous physical exercise for 24 hours prior to the test.

During the Procedure

The collection of a blood sample for Plasma ACTH requires specialized techniques to prevent the rapid degradation of the hormone by plasma peptidases. The procedure is conducted as follows:

• Venipuncture Process: A trained phlebotomist at Chughtai Lab will identify a suitable vein, typically in the antecubital fossa of the arm. The site is cleansed with an antiseptic solution, and a tourniquet is applied briefly to facilitate vein entry.
• Specimen Collection Tube: The blood must be collected in a pre-chilled plastic tube containing Ethylenediaminetetraacetic acid (EDTA) as an anticoagulant. Glass tubes must not be used, as ACTH readily adsorbs to glass surfaces, leading to falsely decreased results.
• Immediate Cold Chain Initiation: Immediately after collection, the tube is gently inverted to mix the blood with the anticoagulant and placed directly into an ice bath. The sample must remain chilled throughout transport to the laboratory.
• Centrifugation and Separation: Within 30 minutes of collection, the sample is centrifuged in a refrigerated centrifuge to separate the plasma from the cellular components. The plasma is then immediately transferred to a plastic transport tube and frozen if the analysis is not performed immediately.
• Patient Experience and Safety: The venipuncture takes only a few minutes and involves minimal discomfort, similar to a brief prick. There are no major safety risks associated with this procedure, though minor bruising or localized soreness at the injection site may occur.

When is a Plasma ACTH Test Performed?

Investigating Cushing’s Syndrome and Cushing’s Disease

Physicians request a Plasma ACTH test when a patient exhibits signs of hypercortisolism, known as Cushing’s syndrome. Clinical symptoms include central obesity, a rounded “moon face,” a dorsocervical fat pad (“buffalo hump”), purple abdominal striae, proximal muscle weakness, and hypertension. The ACTH test is essential to determine if the hypercortisolism is ACTH-dependent (caused by a pituitary adenoma, known as Cushing’s disease, or an ectopic tumor) or ACTH-independent (caused by an autonomous adrenal tumor or exogenous steroid use).

Diagnosing Addison’s Disease (Primary Adrenal Insufficiency)

When patients present with symptoms of hypocortisolemia, such as chronic fatigue, muscle weakness, unexplained weight loss, loss of appetite, low blood pressure (hypotension), and hyperpigmentation of the skin and mucous membranes, primary adrenal insufficiency (Addison’s disease) is suspected. In this condition, the adrenal glands are damaged and cannot produce cortisol. The pituitary gland responds by secreting massive amounts of ACTH. Measuring elevated plasma ACTH levels in the presence of low cortisol confirms a primary adrenal etiology.

Evaluating Secondary and Tertiary Adrenal Insufficiency

Adrenal insufficiency can also occur due to dysfunction of the pituitary gland (secondary) or the hypothalamus (tertiary), often resulting from tumors, head trauma, surgery, radiation, or prolonged corticosteroid therapy. Patients experience symptoms of cortisol deficiency but lack the hyperpigmentation seen in Addison’s disease. The Plasma ACTH test assists in diagnosis by showing low or inappropriately normal ACTH levels despite low circulating cortisol, indicating a failure of the central signaling pathway.

Detecting Ectopic ACTH-Producing Tumors

In some cases, non-endocrine tumors, most commonly small cell lung carcinomas, bronchial carcinoids, or pancreatic islet cell tumors, autonomously secrete ACTH. This leads to a rapid and severe onset of Cushing’s syndrome, often accompanied by profound hypokalemia, muscle wasting, and weight loss. The Plasma ACTH test is critical in these scenarios, as ectopic sources typically produce extremely high levels of ACTH that do not respond to normal physiological feedback mechanisms.

Monitoring Treatment Response in Pituitary or Adrenal Disorders

For patients undergoing treatment for pituitary adenomas, adrenal tumors, or ectopic malignancies, the Plasma ACTH test is used as a monitoring tool. Following transsphenoidal hypophysectomy (surgical removal of a pituitary tumor) or bilateral adrenalectomy, serial measurements of ACTH help clinicians assess the success of the intervention, detect early disease recurrence, and adjust hormone replacement therapies accordingly.

What Does a Plasma ACTH Detect?

The Plasma ACTH test is highly sensitive and detects a wide range of pathological states and physiological variations related to the endocrine system. Specifically, the test can detect and differentiate:

• Pituitary ACTH-Secreting Adenomas (Cushing’s Disease): Characterized by moderately to highly elevated ACTH levels accompanied by high cortisol.
• Primary Adrenal Insufficiency (Addison’s Disease): Indicated by markedly elevated ACTH levels due to the absence of negative feedback from failing adrenal glands.
• Adrenal Adenomas or Carcinomas: Detected when autonomous cortisol production by an adrenal tumor suppresses ACTH secretion to undetectable levels.
• Secondary Adrenal Insufficiency: Identified by low or undetectable ACTH levels in the presence of low cortisol, pointing to pituitary dysfunction.
• Tertiary Adrenal Insufficiency: Characterized by low ACTH and low cortisol resulting from hypothalamic failure or sudden cessation of long-term steroid therapy.
• Ectopic ACTH Syndrome: Indicated by extremely high, non-pulsatile levels of ACTH secreted by malignant or benign extra-pituitary tumors.
• Congenital Adrenal Hyperplasia (CAH): Detected in infants or children with enzyme deficiencies (such as 21-hydroxylase deficiency) where low cortisol leads to compensatory high ACTH.
• Nelson’s Syndrome: Characterized by rapidly rising, extremely high ACTH levels and pituitary enlargement following bilateral adrenalectomy.
• Exogenous Corticosteroid Suppression: Detects the suppressive effect of synthetic glucocorticoids (like dexamethasone or prednisone) on the pituitary gland.
• Loss of Diurnal Variation: Detects early-stage Cushing’s syndrome by demonstrating elevated evening ACTH levels that should normally be low.
• Sheehan’s Syndrome: Detects pituitary necrosis post-partum, presenting as low ACTH and panhypopituitarism.
• Lymphocytic Hypophysitis: An autoimmune inflammation of the pituitary gland resulting in decreased ACTH secretion.
• Hypothalamic Tumors: Detected via low ACTH levels due to impaired CRH stimulation.
• Pituitary Macroadenomas (Non-functioning): Can cause compression of normal pituitary tissue, leading to ACTH deficiency.
• Physiological Stress Response: Detects transiently elevated ACTH levels caused by acute trauma, severe infection, or major surgery.
• Hypoglycemia-Induced ACTH Release: Detects the normal physiological surge of ACTH in response to low blood glucose.
• Cyclical Cushing’s Disease: Detects fluctuating ACTH levels that vary over days, weeks, or months.
• CRH Stimulation Response: Used in dynamic testing to detect exaggerated ACTH responses in pituitary Cushing’s versus flat responses in ectopic ACTH.
• High-Dose Dexamethasone Suppression: Detects a reduction in ACTH levels in pituitary-source Cushing’s, which does not occur in ectopic or adrenal sources.
• Pre-analytical Sample Degradation: Falsely low ACTH levels due to failure to maintain the cold chain or delayed centrifugation.
• Pregnancy-Induced ACTH Elevation: Detects physiological increases in ACTH due to placental production of CRH.
• Drug-Induced ACTH Alterations: Detects the impact of medications like metyrapone, which blocks cortisol synthesis and increases ACTH.

Turnaround Time and Report Access at Chughtai Lab

Chughtai Lab is committed to providing rapid and highly accurate diagnostic reports. For specialized endocrinology tests like the Plasma ACTH, which require precise analytical processing, the turnaround time is typically within 24 to 48 hours. Because of the clinical urgency often associated with endocrine disorders, Chughtai Lab utilizes highly automated chemiluminescent systems that expedite testing without compromising quality.

Patients and referring physicians can access test results seamlessly through multiple digital channels. Once the report is verified by a consultant pathologist, an automated SMS notification is sent to the patient’s registered mobile number. Reports can be viewed, downloaded, and printed directly from the official Chughtai Lab website or via the user-friendly Chughtai Health mobile application. Additionally, patients can opt to receive their reports directly on WhatsApp or collect a physical copy from any of the numerous Chughtai Lab collection centers located across Pakistan.

Plasma ACTH Findings Overview

The interpretation of plasma ACTH levels must always be performed in conjunction with concurrent serum or salivary cortisol measurements. The table below outlines typical clinical findings and their diagnostic implications:

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Morning Plasma ACTH (8:00 AM)	7.2 – 63.3 pg/mL (Assay-dependent)	Elevated (>63.3 pg/mL) or Depressed (<7.2 pg/mL)
Evening Plasma ACTH (4:00 PM)	Approximately 50% of morning value	Elevated (loss of normal diurnal variation)
Primary Adrenal Insufficiency	N/A	Markedly elevated ACTH with low cortisol
Secondary Adrenal Insufficiency	N/A	Low or inappropriately normal ACTH with low cortisol
Cushing’s Disease (Pituitary)	N/A	Moderately elevated to high ACTH with high cortisol
Adrenal Cushing’s Syndrome	N/A	Suppressed ACTH (<5 pg/mL) with high cortisol
Ectopic ACTH Syndrome	N/A	Extremely high ACTH (>200 pg/mL) with high cortisol
Exogenous Glucocorticoid Use	N/A	Suppressed ACTH with suppressed cortisol

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Plasma ACTH?

• Advanced Cold-Chain Logistics: Chughtai Lab maintains a strict cold chain from sample collection to analysis, preventing the degradation of temperature-sensitive hormones like ACTH.
• CAP Proficiency Testing: Chughtai Lab participates in the College of American Pathologists (CAP) proficiency testing, ensuring international standards of diagnostic accuracy.
• ISO 15189 Certification: The laboratory operates under ISO 15189 certification, demonstrating compliance with global medical laboratory quality standards.
• State-of-the-Art Technology: Utilizing advanced chemiluminescent immunoassay (CLIA) platforms for highly sensitive and specific hormone quantification.
• Convenient Home Sampling: Patients can avail themselves of professional home sample collection services across major cities in Pakistan, minimizing physical stress before the test.
• Expert Pathologist Oversight: Every specialized report is reviewed and signed off by highly qualified consultant pathologists and clinical biochemists.
• Seamless Digital Access: Quick and easy retrieval of diagnostic reports via the Chughtai Health App, official website, and WhatsApp.
• Nationwide Network: With over 300 collection centers across Pakistan, patients have convenient access to high-quality diagnostic services close to home.